Market Survey on Americas COVID-19 Testing Market Covering Sales Outlook, Up-to-date Key Trends, Market Size and Forecast, Per Capita Expenditure, Company Share, Brand Share, Regulations, Reimbursement Scenario, Epidemiology, Procedure Numbers, and Pipeline Assessment
An In-depth Market Insights of Americas COVID-19 Testing Market including SARS-CoV2 IgM/IgG Antibody Rapid Test Kits, SARS-CoV-2 Antigen Rapid Test Kits, and Multiplex Real-time RT-PCR Assay Kits Covering 30+ Countries like United States, United Kingdom, Germany, France, Norway, Sweden, Saudi Arabia, United Arab Emirates, Japan, Korea, Australia, New Zealand, and Others
Americas COVID-19 Testing Market Outlook (2023 to 2033)
Americas COVID-19 testing market valuation is at US$ 5.1 billion in 2023 and is likely to be valued at US$ 9.8 billion by 2033. The sales of AmericasCOVID-19 testing are expected to rise at a CAGR of 6.7% during the forecast period.
Detection of Early Virus Increase the Adoption of Americas COVID-19 Testing
The outbreak of COVID-19 waves rapidly spread all around the globe with a high risk of morbidity is estimated to raise the demand for Americas COVID-19 testing.
The rising demand for sampling kits due to high mortality risk is increasing the adoption of Americas COVID-19 testing during the forecast period.
The growing health concerns among people and the spreading COVID-19 virus drive the market expansion.
The rising symptoms such as cough, fever, cold, and body pain are increasing the demand for Americas COVID-19 testing kits.
The rising demand for Americas COVID-19 testing kits to detect and reduce the spread of the virus is growing market share.
The adoption of Nasopharyngeal swab samples is commonly preferred due to their high availability are growing market size.
The popularity of e-commerce and online sales is increasing the adoption of Americas COVID-19 testing in social distancing.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Complications in Americas COVID-19 Testing Decline Market Growth
The rising risk of diagnostic problems in testing is limiting the market growth. In addition, several complications in testing equipment are slowing down the market size.
Launching vaccine doses to control COVID-19 cases may restrain the market growth. In addition, the unavailability of COVID-19 testing may limit the market's growth.
Efforts of Front-line Leaders Increase Market Opportunities
The outbreak of the COVID-19 virus has destroyed human life in the last three years. However, the front-line workers and healthcare experts continue to work overtime to detect diseases and provide vaccination doses, which are rapidly growing market opportunities. In a report by the WHO, in Mar 2020, in the global market, death rates rose up to 18,000. Therefore, normalizing the situation and treating patients are estimated to increase the demand for Americas COVID-19 testing.
Manufacturers are developing diagnostic kits to reduce the spread of the COVID-19 virus from one person to another. The Drug Controller of India approved Diagnostic Kit for doctors to treat COVID-19 patients in recent times.
Find your sweet spots for generating winning opportunities in this market.
Americas COVID-19 Testing Market 2017 to 2022 Historic Sales Compared to 2023 to 2033 Future Outlook
According to Future Market Insights (FMI), the sales of Americas COVID-19 testing kitsare expected to grow at a CAGR of 6.7% during the forecast period. The SARS-Cov-2 virus is highly infectious and can spread at a very high rate. It can cause health concerns such as mild fever, cough, cold, and body aches. If left unchecked, it might even prove fatal.
To detect the virus early and to reduce its spread, it is essential to diagnose the presence of infection in the human body. Furthermore, early detection aids in timely treatment that can help control symptoms and offer better patient care. Therefore, the market grew at a CAGR of 8.4% from 2017 to 2022.
Short Term (2022 to 2025): The rising demand for Americas COVID-19 testing to detect the virus among patients drives the market growth.
Medium Term (2025 to 2028): The rising awareness of health concerns and symptoms is increasing the adoption of Americas COVID-19 testing.
Long Term (2028 to 2032): Sales from eCommerce channels to drive the market during the forecast period.
The market is estimated to reach US$ 9.8 billion during the forecast period. In the historical period, the market stood at a valuation of US$ 4.8 billion from 2017 to 2022.
Comparative Analysis of Adjacent Markets
Americas COVID-19 Testing Market:
Attributes
Americas COVID-19 Testing Market
CAGR (2023 to 2033)
6.7%
Value (2023)
US$ 5.1 billion
Value (2033)
US$ 9.8 billion
Trends
The increasing online shopping is expanding the market during the forecast period.
Opportunities
The rising awareness of health concerns and symptoms is increasing the adoption of Americas COVID-19 testing
COVID-19 Diagnostics Market:
Attributes
COVID-19 Diagnostics Market
CAGR (2023 to 2033)
7.5%
Value (2023)
US$ 112.56 billion
Value (2033)
US$ 231.99 billion
Trends
Rising population, lack of drug and manufacturing diagnostic kits
Opportunities
The rising key players, governments regulations, and emerging Start-ups
Software Testing Market:
Attributes
Software Testing Market
CAGR (2023 to 2033)
6%
Value (2023)
US$ 50.50 billion
Value (2033)
US$ 90.44 billion
Trends
Rising demand for better cloud systems with minimal error
Opportunities
Growing adoption of software testing in healthcare and manufacturing industries
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Top Two Segment in the Market
Segments
Test Type
Top Category
SARS-CoV2 IgM/IgG Antibody Rapid Test Kits
Historic CAGR
8.2%
Forecast CAGR
6.0%
Segments
Sample Type
Top Category
Blood
Historic CAGR
7.9%
Forecast CAGR
5.6%
How are SARS-CoV-2 IgM/IgG Antibody Rapid Test Kits Contributing to Revenue Generation?
Based on test type, the market is categorized into SARS-CoV2 IgM/IgG Antibody Rapid Test Kits, SARS-CoV-2 Antigen Rapid Test Kits, and Multiplex Real-time RT-PCR Assay Kits. SARS-CoV-2 IgM/IgG Antibodyrapid test kits have a higher potential for growth in the coming years. As a result, the segment is estimated to capture a high CAGR of 6.0% during the forecast period.
Preference for antibody rapid testing kits among healthcare providers promotes the growth of this segment in the long term. Adopting SARS-CoV-2 IgM/IgG Antibody rapid test kits to screen and detect patients' COVID-19 infections is driving market share. As a result, the category secured a CAGR of 8.2% in the historical period from 2017 to 2022.
Blood is the Most Sought-after Category in the Sample Type Segment
The global market is categorized into the blood and nasopharyngeal swabs based on sample type. The blood sample type category dominates the global market by securing a CAGR of 5.6% during the forecast period. Furthermore, collecting blood samples to detect patients' health and bringing out plasma therapy to treat patients significantly increase the demand for blood samples. As a result, the category secured a CAGR of 7.9% in the historical period from 2017 to 2022.
What is the Scope of Growth for Online Sales Channels?
Despite hospital pharmacies leading the market, online sales channels are expected to experience significant growth in the Americas COVID-19 testing market. The online sales channels contribute a CAGR of 6.8% for the duration of the forecast period. The primarily attributed to higher acceptance of online sales and convenience to users along with discounts and offers reducing costs through home deliveries.
Top Countries Data Table Mentioned Below:
Country
USA
CAGR (2017 to 2022)
8.1%
CAGR (2023 to 2023)
6.5%
Valuation (2023 to 2033)
3.5 billion
Country
United Kingdom
CAGR (2017 to 2022)
7.1%
CAGR (2023 to 2023)
5.8%
Valuation (2023 to 2033)
412.4 million
Country
China
CAGR (2017 to 2022)
7.7%
CAGR (2023 to 2023)
6.2%
Valuation (2023 to 2033)
703.2 million
Country
Japan
CAGR (2017 to 2022)
6.6%
CAGR (2023 to 2023)
5.3%
Valuation (2023 to 2033)
574.8 million
Country
South Korea
CAGR (2017 to 2022)
5.3%
CAGR (2023 to 2023)
4.5%
Valuation (2023 to 2033)
338.1 million
How is the COVID-19 Testing Market Faring in the USA?
During the forecast period, the USA is securing a CAGR of 6.5% with a valuation of US$ 3.5 billion. Research collaborations and license agreements for healthcare products lead the USA market. Recent technological advancements will create opportunities for the development of innovative products. Key players are currently focusing on strategies, including acquisitions and mergers, in addition to new product launches in the region.
For instance, in June 2020, the Novacyt Group announced the launch of three products for Americas COVID-19 testing market. The products are Exsig™ Direct, Exsig™ Mag, i.e. RNA extraction kits, and COVID-HT test, i.e. a high-throughput test for COVID-19. These products are going to support the COVID-19 diagnosis segment of the company. As a result, the USA market secured a CAGR of 8.1% in the historical period from 2017 to 2022.
What Factors are Driving Growth in the United Kingdom?
The United Kingdom market is estimated to secure a CAGR of 5.8% with a valuation of US$ 412.4 million during the forecast period. The rising prevalence of COVID-19 infections and technological advancements in the healthcare sector are key factors that propel the United Kingdom COVID-19 testing market.
Besides this, favorable reimbursement policies of the United Kingdom government continue to create opportunities for market growth during the forecast period. As a result, the United Kingdom market secured a CAGR of 7.1% in the historical period from 2017 to 2022.
What Opportunities will Manufacturers Capitalize for China Market Growth?
China is contributing a CAGR of 6.2% with a valuation of US$ 703.2 million in the global market through the forecast period. Key players in the country mainly focus on expanding their market presence in the Americas. Steps taken by the government in China to contain the virus have been a key growth enabler.
The World Health Organization (WHO) announced the novel coronavirus outbreak as a public health emergency; China actively readied for the pandemic. The Ministry of Health in the country established an Emergency Operations Centre (COE) to prepare the healthcare system to respond actively to a medical emergency.
Substantial progress in actions taken to contain the unprecedented outbreak created attractive prospects for the COVID-19 testing market in the country. The China market secured a CAGR of 7.7% in the historical period from 2017 to 2022.
Competitive Landscape in the Americas COVID-19 Testing Market
Manufacturers in the Americas COVID-19 testing market are primarily aiming at strategic acquisitions, collaborations, and launches of innovative products to cater to the market demand. In addition, production capacity expansion is also likely to gain traction as global demand for testing continues to rise rapidly.
The prominent manufacturers keep their eye on the patient's requirements to launch better testing equipment during the forecast period. Moreover, prominent vendors are setting goals to fight against several COVID-19 variants. At present, the fast-spreading coronavirus variant in other countries is estimated to raise the production of Americas COVID-19 testing by manufacturers.
Some of the leading companies operating in the market are
Sky Medical Supplies & Equipment LLC.
Sugentech, Inc.
Novacyt Group
Aurora Instruments Ltd.
PRIMA Lab SA
SD Biosensor, INC.
Gold Standard Diagnostics
Eurofins Technologies
Biomerieux SA
Danaher
Recent Developments in the Americas COVID-19 Testing Market:
For instance, Sugentech, Inc. began the distribution of the SGTi-flex COVID-19 IgM/IgG test kit after gaining FDA approval in April 2020.
In August 2020, Novacyt Group launched Winterplex&trade, a CE-Mark-approved polymerase chain reaction (PCR) respiratory test panel, which is a real-time PCR detection of multiple viruses.
In May 2020, Biomerieux SA announced the launch of the VIDAS anti-SARS-CoV-2 serology tests, which detect the presence of antibodies in the body for SARS-COV-2. The product has received a CE mark.
Scope of Report
Attribute
Details
Forecast Period
2023 to 2033
Historical Data Available for
2017 to 2022
Market Analysis
US$ billion for Value
Key Countries Covered
USA, Canada, Germany, United Kingdom, France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, and South Africa
Key Segments Covered
Test Type
Sample Type
Distribution Channel
Region
Key Companies Profiled
Sky Medical Supplies & Equipment LLC.
Sugentech, Inc.
Novacyt Group
Aurora Instruments Ltd.
PRIMA Lab SA
SD Biosensor, INC.
Gold Standard Diagnostics
Eurofins Technologies
Biomerieux SA
Danaher
Report Coverage
Market Forecast, Company Share Analysis, Competition Intelligence, Drivers, Restraints, Opportunities and Threats Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives
Customization & Pricing
Available upon Request
Americas COVID-19 Testing Market by Category
By Test Type:
SARS-CoV2 IgM/IgG Antibody Rapid Test Kits
SARS-CoV-2 Antigen Rapid Test Kits
Multiplex Real-time RT-PCR Assay Kits
By Sample Type:
Blood
Nasopharyngeal Swabs
By Distribution Channel:
Hospital Pharmacies
Diagnostic Laboratories
Retail Pharmacies
Drug Store
Online Sales Channel
By Region:
North America
Latin America
Europe
South Asia & Pacific
East Asia
Middle East & Africa (MEA)
Frequently Asked Questions
Which Was the Widely Popular COVID-19 Test Type?
SARS-CoV-2 IgM/IgG antibody rapid test kits was the widely popular COVID-19 test type.
How was the Historical Performance of the COVID-19 Testing Market in America?
The United States market recorded a CAGR of 8.1% in 2022.
How was the Historical Performance of the COVID-19 Testing Market in the United Kingdom?
The market recorded a CAGR of 7.1% in 2022.
How was the Historical Performance of the COVID-19 Testing Market in China?
The market recorded a CAGR of 7.7% in 2022.
Who are the Key Americas COVID-19 Testing Market Players?
Sky Medical Supplies & Equipment LLC., Sugentech, Inc., and Novacyt Group are key Americas COVID-19 testing market players.
Table of Content
1. Executive Summary | Americas COVID-19 Testing Market
1.1. Americas Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Market Analysis 2017 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ million) & Volume (Units) Analysis, 2017 to 2022
4.2. Current and Future Market Size Value (US$ million) & Volume (Units) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Test Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By Test Type, 2017 to 2022
5.3. Current and Future Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By Test Type, 2023 to 2033
5.3.1. SARS-CoV-2 IgM/IgG Antibody Rapid Test Kits
5.3.2. SARS-CoV-2 Antigen Rapid Test Kits
5.3.3. Multiplex Real-Time RT-PCR Assay Kits
5.4. Y-o-Y Growth Trend Analysis By Test Type, 2017 to 2022
5.5. Absolute $ Opportunity Analysis By Test Type, 2023 to 2033
6. Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Sample Type
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By Sample Type, 2017 to 2022
6.3. Current and Future Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By Sample Type, 2023 to 2033
6.3.1. Blood
6.3.2. Nasopharyngeal Swabs
6.4. Y-o-Y Growth Trend Analysis By Sample Type, 2017 to 2022
6.5. Absolute $ Opportunity Analysis By Sample Type, 2023 to 2033
7. Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Distribution Channel
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By Distribution Channel, 2017 to 2022
7.3. Current and Future Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By Distribution Channel, 2023 to 2033
7.3.1. Hospital Pharmacies
7.3.2. Diagnostic Laboratories
7.3.3. Retail Pharmacies
7.3.4. Drug Store
7.3.5. Online Sales Channels
7.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2017 to 2022
7.5. Absolute $ Opportunity Analysis By Distribution Channel, 2023 to 2033
8. Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By Region, 2017 to 2022
8.3. Current Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
9.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Test Type
9.2.3. By Sample Type
9.2.4. By Distribution Channel
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Test Type
9.3.3. By Sample Type
9.3.4. By Distribution Channel
9.4. Key Takeaways
10. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
10.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Argentina
10.2.2. By Test Type
10.2.3. By Sample Type
10.2.4. By Distribution Channel
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Test Type
10.3.3. By Sample Type
10.3.4. By Distribution Channel
10.4. Key Takeaways
11. Key Countries Market Analysis
11.1. USA
11.1.1. Pricing Analysis
11.1.2. Market Share Analysis, 2022
11.1.2.1. By Test Type
11.1.2.2. By Sample Type
11.1.2.3. By Distribution Channel
11.2. Canada
11.2.1. Pricing Analysis
11.2.2. Market Share Analysis, 2022
11.2.2.1. By Test Type
11.2.2.2. By Sample Type
11.2.2.3. By Distribution Channel
11.3. Brazil
11.3.1. Pricing Analysis
11.3.2. Market Share Analysis, 2022
11.3.2.1. By Test Type
11.3.2.2. By Sample Type
11.3.2.3. By Distribution Channel
11.4. Mexico
11.4.1. Pricing Analysis
11.4.2. Market Share Analysis, 2022
11.4.2.1. By Test Type
11.4.2.2. By Sample Type
11.4.2.3. By Distribution Channel
11.5. Argentina
11.5.1. Pricing Analysis
11.5.2. Market Share Analysis, 2022
11.5.2.1. By Test Type
11.5.2.2. By Sample Type
11.5.2.3. By Distribution Channel
12. Market Structure Analysis
12.1. Competition Dashboard
12.2. Competition Benchmarking
12.3. Market Share Analysis of Top Players
12.3.1. By Regional
12.3.2. By Test Type
12.3.3. By Sample Type
12.3.4. By Distribution Channel
13. Competition Analysis
13.1. Competition Deep Dive
13.1.1. Sky Medical Supplies & Equipment LLC.
13.1.1.1. Overview
13.1.1.2. Product Portfolio
13.1.1.3. Profitability by Market Segments
13.1.1.4. Sales Footprint
13.1.1.5. Strategy Overview
13.1.1.5.1. Marketing Strategy
13.1.1.5.2. Product Strategy
13.1.1.5.3. Channel Strategy
13.1.2. Sugentech, Inc.
13.1.2.1. Overview
13.1.2.2. Product Portfolio
13.1.2.3. Profitability by Market Segments
13.1.2.4. Sales Footprint
13.1.2.5. Strategy Overview
13.1.2.5.1. Marketing Strategy
13.1.2.5.2. Product Strategy
13.1.2.5.3. Channel Strategy
13.1.3. Novacyt Group
13.1.3.1. Overview
13.1.3.2. Product Portfolio
13.1.3.3. Profitability by Market Segments
13.1.3.4. Sales Footprint
13.1.3.5. Strategy Overview
13.1.3.5.1. Marketing Strategy
13.1.3.5.2. Product Strategy
13.1.3.5.3. Channel Strategy
13.1.4. Aurora Instruments Ltd.
13.1.4.1. Overview
13.1.4.2. Product Portfolio
13.1.4.3. Profitability by Market Segments
13.1.4.4. Sales Footprint
13.1.4.5. Strategy Overview
13.1.4.5.1. Marketing Strategy
13.1.4.5.2. Product Strategy
13.1.4.5.3. Channel Strategy
13.1.5. PRIMA Lab SA
13.1.5.1. Overview
13.1.5.2. Product Portfolio
13.1.5.3. Profitability by Market Segments
13.1.5.4. Sales Footprint
13.1.5.5. Strategy Overview
13.1.5.5.1. Marketing Strategy
13.1.5.5.2. Product Strategy
13.1.5.5.3. Channel Strategy
13.1.6. SD Biosensor, INC.
13.1.6.1. Overview
13.1.6.2. Product Portfolio
13.1.6.3. Profitability by Market Segments
13.1.6.4. Sales Footprint
13.1.6.5. Strategy Overview
13.1.6.5.1. Marketing Strategy
13.1.6.5.2. Product Strategy
13.1.6.5.3. Channel Strategy
13.1.7. Gold Standard Diagnostics
13.1.7.1. Overview
13.1.7.2. Product Portfolio
13.1.7.3. Profitability by Market Segments
13.1.7.4. Sales Footprint
13.1.7.5. Strategy Overview
13.1.7.5.1. Marketing Strategy
13.1.7.5.2. Product Strategy
13.1.7.5.3. Channel Strategy
13.1.8. Eurofins Technologies
13.1.8.1. Overview
13.1.8.2. Product Portfolio
13.1.8.3. Profitability by Market Segments
13.1.8.4. Sales Footprint
13.1.8.5. Strategy Overview
13.1.8.5.1. Marketing Strategy
13.1.8.5.2. Product Strategy
13.1.8.5.3. Channel Strategy
13.1.9. Biomerieux SA
13.1.9.1. Overview
13.1.9.2. Product Portfolio
13.1.9.3. Profitability by Market Segments
13.1.9.4. Sales Footprint
13.1.9.5. Strategy Overview
13.1.9.5.1. Marketing Strategy
13.1.9.5.2. Product Strategy
13.1.9.5.3. Channel Strategy
13.1.10. Danaher
13.1.10.1. Overview
13.1.10.2. Product Portfolio
13.1.10.3. Profitability by Market Segments
13.1.10.4. Sales Footprint
13.1.10.5. Strategy Overview
13.1.10.5.1. Marketing Strategy
13.1.10.5.2. Product Strategy
13.1.10.5.3. Channel Strategy
14. Assumptions & Acronyms Used15. Research Methodology
List of Tables
Table 1: Market Value (US$ million) Forecast by Region, 2017 to 2033
Table 2: Market Volume (Units) Forecast by Region, 2017 to 2033
Table 3: Market Value (US$ million) Forecast by Test Type, 2017 to 2033
Table 4: Market Volume (Units) Forecast by Test Type, 2017 to 2033
Table 5: Market Value (US$ million) Forecast by Sample Type, 2017 to 2033
Table 6: Market Volume (Units) Forecast by Sample Type, 2017 to 2033
Table 7: Market Value (US$ million) Forecast by Distribution Channel, 2017 to 2033
Table 8: Market Volume (Units) Forecast by Distribution Channel, 2017 to 2033
Table 9: North America Market Value (US$ million) Forecast by Country, 2017 to 2033
Table 10: North America Market Volume (Units) Forecast by Country, 2017 to 2033
Table 11: North America Market Value (US$ million) Forecast by Test Type, 2017 to 2033
Table 12: North America Market Volume (Units) Forecast by Test Type, 2017 to 2033
Table 13: North America Market Value (US$ million) Forecast by Sample Type, 2017 to 2033
Table 14: North America Market Volume (Units) Forecast by Sample Type, 2017 to 2033
Table 15: North America Market Value (US$ million) Forecast by Distribution Channel, 2017 to 2033
Table 16: North America Market Volume (Units) Forecast by Distribution Channel, 2017 to 2033
Table 17: Latin America Market Value (US$ million) Forecast by Country, 2017 to 2033
Table 18: Latin America Market Volume (Units) Forecast by Country, 2017 to 2033
Table 19: Latin America Market Value (US$ million) Forecast by Test Type, 2017 to 2033
Table 20: Latin America Market Volume (Units) Forecast by Test Type, 2017 to 2033
Table 21: Latin America Market Value (US$ million) Forecast by Sample Type, 2017 to 2033
Table 22: Latin America Market Volume (Units) Forecast by Sample Type, 2017 to 2033
Table 23: Latin America Market Value (US$ million) Forecast by Distribution Channel, 2017 to 2033
Table 24: Latin America Market Volume (Units) Forecast by Distribution Channel, 2017 to 2033
List of Charts
Figure 1: Market Value (US$ million) by Test Type, 2023 to 2033
Figure 2: Market Value (US$ million) by Sample Type, 2023 to 2033
Figure 3: Market Value (US$ million) by Distribution Channel, 2023 to 2033
Figure 4: Market Value (US$ million) by Region, 2023 to 2033
Figure 5: Market Value (US$ million) Analysis by Region, 2017 to 2033
Figure 6: Market Volume (Units) Analysis by Region, 2017 to 2033
Figure 7: Market Value Share (%) and BPS Analysis by Region, 2023 to 2033
Figure 8: Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033
Figure 9: Market Value (US$ million) Analysis by Test Type, 2017 to 2033
Figure 10: Market Volume (Units) Analysis by Test Type, 2017 to 2033
Figure 11: Market Value Share (%) and BPS Analysis by Test Type, 2023 to 2033
Figure 12: Market Y-o-Y Growth (%) Projections by Test Type, 2023 to 2033
Figure 13: Market Value (US$ million) Analysis by Sample Type, 2017 to 2033
Figure 14: Market Volume (Units) Analysis by Sample Type, 2017 to 2033
Figure 15: Market Value Share (%) and BPS Analysis by Sample Type, 2023 to 2033
Figure 16: Market Y-o-Y Growth (%) Projections by Sample Type, 2023 to 2033
Figure 17: Market Value (US$ million) Analysis by Distribution Channel, 2017 to 2033
Figure 18: Market Volume (Units) Analysis by Distribution Channel, 2017 to 2033
Figure 19: Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033
Figure 20: Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033
Figure 21: Market Attractiveness by Test Type, 2023 to 2033
Figure 22: Market Attractiveness by Sample Type, 2023 to 2033
Figure 23: Market Attractiveness by Distribution Channel, 2023 to 2033
Figure 24: Market Attractiveness by Region, 2023 to 2033
Figure 25: North America Market Value (US$ million) by Test Type, 2023 to 2033
Figure 26: North America Market Value (US$ million) by Sample Type, 2023 to 2033
Figure 27: North America Market Value (US$ million) by Distribution Channel, 2023 to 2033
Figure 28: North America Market Value (US$ million) by Country, 2023 to 2033
Figure 29: North America Market Value (US$ million) Analysis by Country, 2017 to 2033
Figure 30: North America Market Volume (Units) Analysis by Country, 2017 to 2033
Figure 31: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 32: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 33: North America Market Value (US$ million) Analysis by Test Type, 2017 to 2033
Figure 34: North America Market Volume (Units) Analysis by Test Type, 2017 to 2033
Figure 35: North America Market Value Share (%) and BPS Analysis by Test Type, 2023 to 2033
Figure 36: North America Market Y-o-Y Growth (%) Projections by Test Type, 2023 to 2033
Figure 37: North America Market Value (US$ million) Analysis by Sample Type, 2017 to 2033
Figure 38: North America Market Volume (Units) Analysis by Sample Type, 2017 to 2033
Figure 39: North America Market Value Share (%) and BPS Analysis by Sample Type, 2023 to 2033
Figure 40: North America Market Y-o-Y Growth (%) Projections by Sample Type, 2023 to 2033
Figure 41: North America Market Value (US$ million) Analysis by Distribution Channel, 2017 to 2033
Figure 42: North America Market Volume (Units) Analysis by Distribution Channel, 2017 to 2033
Figure 43: North America Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033
Figure 44: North America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033
Figure 45: North America Market Attractiveness by Test Type, 2023 to 2033
Figure 46: North America Market Attractiveness by Sample Type, 2023 to 2033
Figure 47: North America Market Attractiveness by Distribution Channel, 2023 to 2033
Figure 48: North America Market Attractiveness by Country, 2023 to 2033
Figure 49: Latin America Market Value (US$ million) by Test Type, 2023 to 2033
Figure 50: Latin America Market Value (US$ million) by Sample Type, 2023 to 2033
Figure 51: Latin America Market Value (US$ million) by Distribution Channel, 2023 to 2033
Figure 52: Latin America Market Value (US$ million) by Country, 2023 to 2033
Figure 53: Latin America Market Value (US$ million) Analysis by Country, 2017 to 2033
Figure 54: Latin America Market Volume (Units) Analysis by Country, 2017 to 2033
Figure 55: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 56: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 57: Latin America Market Value (US$ million) Analysis by Test Type, 2017 to 2033
Figure 58: Latin America Market Volume (Units) Analysis by Test Type, 2017 to 2033
Figure 59: Latin America Market Value Share (%) and BPS Analysis by Test Type, 2023 to 2033
Figure 60: Latin America Market Y-o-Y Growth (%) Projections by Test Type, 2023 to 2033
Figure 61: Latin America Market Value (US$ million) Analysis by Sample Type, 2017 to 2033
Figure 62: Latin America Market Volume (Units) Analysis by Sample Type, 2017 to 2033
Figure 63: Latin America Market Value Share (%) and BPS Analysis by Sample Type, 2023 to 2033
Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Sample Type, 2023 to 2033
Figure 65: Latin America Market Value (US$ million) Analysis by Distribution Channel, 2017 to 2033
Figure 66: Latin America Market Volume (Units) Analysis by Distribution Channel, 2017 to 2033
Figure 67: Latin America Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033
Figure 68: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033
Figure 69: Latin America Market Attractiveness by Test Type, 2023 to 2033
Figure 70: Latin America Market Attractiveness by Sample Type, 2023 to 2033
Figure 71: Latin America Market Attractiveness by Distribution Channel, 2023 to 2033
Figure 72: Latin America Market Attractiveness by Country, 2023 to 2033
